How injection drug users coped with testing HIV-seropositive: implications for subsequent health-related behaviors.
At entry into methadone maintenance treatment, 94 HIV-positive injection drug users (IDUs) completed the Coping Reponses Inventory, which asked them to "describe your feelings and experiences when you first learned you were HIV positive." Controlling for time since HIV testing, a reliance on avoidance coping following HIV testing was correlated with high levels of recent HIV risk behavior and poor health at entry into the study. The use of any coping strategy, particularly approach strategies, was related to medication adherence. Hierarchical regression analysis showed that avoidance coping accounted for a significant proportion of the variance in recent HIV risk behavior over and above that accounted for by the other variables. Other independent predictors of continued risk behavior were poor health, lack of social support, and low levels of HIV/AIDS knowledge. The need for interventions to help injection drug users (IDUs) cope subsequent to testing HIV seropositive is discussed.
Avants
S K
SK
Yale University School of Medicine, Division of Substance Abuse, New Haven, CT 06519, USA. kelly.avants@yale.edu
Warburton
L A
LA
Margolin
A
A
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000223:Adaptation, Psychological; D000328:Adult; D003627:Data Interpretation, Statistical; D004493:Education; D005260:Female; D006679:HIV Seropositivity / Q000150:complications / Q000523:psychology; D015438:Health Behavior; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use; D009294:Narcotics / Q000627:therapeutic use; D010552:Personality Assessment; D012044:Regression Analysis; D012309:Risk-Taking; D012944:Social Support; D015819:Substance Abuse, Intravenous / Q000150:complications / Q000188:drug therapy / Q000523:psychology
D009294:Narcotics; D008691:Methadone